Medable

Founded in 2012 in Palo Alto by Stanford-trained physician-scientist Michelle Longmire alongside Tim Smith and James Sas, Medable builds software that lets pharmaceutical sponsors and CROs run hybrid and fully decentralized clinical trials. Its platform spans electronic consent, electronic clinical outcome assessment (eCOA/ePRO), televisits, BYOD/wearables data capture and an AI-powered Study Studio that compresses study build timelines. Medable raised a $304M Series D in October 2021 led by Blackstone Growth, GSR Ventures and Tiger Global at a $2.1B valuation, bringing total capital raised to roughly $521M. The company has since gone through multiple rounds of layoffs as it pursues profitability and is investing heavily in agentic AI tools for trial operations.

Medable was the first decentralized clinical trial platform to reach unicorn status and remains one of the most widely deployed eConsent and eCOA stacks in pharma — making it a bellwether for whether DCT software can survive the post-pandemic normalization and the new wave of AI-native trial operations tools.

medable.com Decentralized Clinical Trials

United Statesprivate

At a glance

Total raised

$521M

last round series d

Headcount

201-500

approximate · public range

Headquarters

Palo Alto

United States

Founded

2012

14 years active

Status

Private

Decentralized Clinical Trials

Latest valuation

$2.1B

Series D · 2021

For subscribers

Subscribe to see the full profile

Including Funding rounds, Bull / Bear thesis, Stock + earnings, Roster changes, Patents, News, and Open roles.

Founding

50% off

/month

94 of 100 spots left

Full

$10

/month

Available once all 100 Founding Member spots are claimed.

Get full access

Already subscribed? Sign in →

Funding history

Total raised

$521M

Rounds tracked

Latest stage

Series D

Latest valuation

$2.1B

Date	Stage	Amount	Valuation	Lead investors
Oct 26, 2021	Series D	$304M	$2.1B	Blackstone Growth, GSR Ventures, Tiger Global

Founder backgrounds

James Sas

Co-founder

Co-founder and Chief Architect of Medable. Previously worked at Disney Interactive as a game programmer before shifting into healthcare technology. Founded OnThread, a company where he served as lead architect. Has a background in business intelligence frameworks and cloud systems design, with over 20 years of engineering experience spanning graph databases, NoSQL, and real-time web technologies. His technical architecture work at Medable underpins the platform's decentralized clinical trial infrastructure, including eConsent, eCOA/ePRO, and televisits operating across 60+ countries.

Michelle Longmire

Co-founder & CEO

A Stanford-trained physician-scientist who practiced as a dermatologist and conducted postdoctoral research at Stanford before founding Medable. She earned her medical degree from the University of New Mexico School of Medicine, completed her dermatology residency at Stanford, and remained on faculty. Witnessing firsthand how logistical barriers slowed clinical trial enrollment and drug development, she left clinical practice to build Medable — her first company — which became a leading decentralized clinical trial platform. A former champion soccer player, she has frequently cited team sports as a formative influence on her leadership, instilling a relentless, mission-first approach to accelerating therapies to patients.

Tim Smith

Co-founder

Prior to Medable, Smith co-founded and served as CTO of ClosedWon, an enterprise cloud development company he built from two people to over 25, delivering healthcare-focused cloud solutions. Earlier, he was Director of Operations at ZTEC Instruments. He studied at the University of Texas at Austin. That experience building cloud-native healthcare tools directly informed Medable's approach to decentralizing clinical trials with a no-code platform that cuts study setup from months to hours. Smith is also the named inventor on multiple Medable patents related to electronic consent and telehealth systems for clinical research.

AI bull / bear

AI bull / bear analysis hasn’t been generated for this company yet. Cases refresh quarterly using the latest classified articles and funding history.

In the news

Medable · last 30 days

No articles ingested yet for Medable. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.

Leadership

Michelle Longmire

Co-founder & CEO & Chief Executive Officer

Tim Smith

Co-founder

—

James Sas

Co-founder

—

Products

eCOA+
Medable's electronic clinical outcome assessment platform captures patient-reported, clinician-reported and observer-reported outcomes on participants' own devices or provisioned hardware. It supports BYOD deployments, wearables and remote patient monitoring data, with localization across 120+ languages and validated migration of legacy paper instruments. The product is a workhorse for sponsors running hybrid and fully decentralized studies and has been deployed in trials reporting 90%+ participant adherence and double-digit reductions in translation timelines.
Total Consent
Total Consent is Medable's electronic informed consent (eConsent) solution, allowing trial participants to review, sign and re-consent on study protocols remotely from any device. It supports multimedia explainers, comprehension checks, multi-language deployments and integrated identity verification, with audit trails designed to meet 21 CFR Part 11, GDPR and ICH GCP requirements. Total Consent is widely used to accelerate site activation, reduce screen-fail rates and broaden geographic recruitment for decentralized and hybrid studies.
Study Studio
Study Studio is Medable's AI-powered, no-code trial build environment that lets sponsors and CROs configure, translate and deploy eCOA, eConsent and televisit experiences in as little as one business day. It replaces the multi-week, vendor-led builds that have historically dominated DCT software with a self-serve toolchain, with reusable templates and automated translation workflows aimed at compressing study start-up costs and timelines for sponsors running large global protocol portfolios.
Agent Platform
Medable's Agent Platform is a suite of agentic AI tools for clinical operations, including a Site Monitoring (CRA) Agent, a Trial Master File (TMF) Agent and a PI Summary and Review Agent. The agents automate document review, query generation, monitoring visit prep and TMF reconciliation across the lifecycle of a trial, positioning Medable's stack against new AI-native entrants and incumbent CTMS/eTMF vendors as sponsors look to consolidate spend on AI-driven trial execution.

Open roles

We don't have a live feed for this company's ATS. Their careers page has every open role.

View all careers ↗